CENTRE GEORGES FRANCOIS LECLERC

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Predictive Study of Radiation Induced Sarcoma

First Posted Date
2012-01-05
Last Posted Date
2017-06-12
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
360
Registration Number
NCT01504360
Locations
🇫🇷

CGFL, Dijon, France

Spectro-IRM and Evaluation Response to Prostatic Radiotherapy

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Other: MR-Spectroscopy
First Posted Date
2011-08-09
Last Posted Date
2017-06-21
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
90
Registration Number
NCT01412853
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, France

Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas

Early Phase 1
Terminated
Conditions
Non-small Cell Lung Cancer Metastatic
Interventions
Biological: CTC
First Posted Date
2011-06-27
Last Posted Date
2020-01-27
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
30
Registration Number
NCT01380795
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, France

Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus

First Posted Date
2011-05-05
Last Posted Date
2020-01-27
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
196
Registration Number
NCT01348217
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, France

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

First Posted Date
2011-05-05
Last Posted Date
2018-07-16
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
31
Registration Number
NCT01348412
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, France

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

First Posted Date
2010-09-29
Last Posted Date
2013-08-07
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
200
Registration Number
NCT01210872
Locations
🇫🇷

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France

Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

Phase 1
Completed
Conditions
Metastatic Breast Cancer
Interventions
Drug: lapatinib
Drug: docetaxel
First Posted Date
2010-01-08
Last Posted Date
2012-09-25
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
17
Registration Number
NCT01044485
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, Bourgogne, France

Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults

Phase 1
Completed
Conditions
Glioblastoma
Interventions
Radiation: radiotherapy
Drug: temozolomide
First Posted Date
2010-01-06
Last Posted Date
2012-09-25
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
10
Registration Number
NCT01043536
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, Bourgogne, France

Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma

First Posted Date
2009-12-01
Last Posted Date
2012-09-25
Lead Sponsor
Centre Georges Francois Leclerc
Target Recruit Count
134
Registration Number
NCT01022918
Locations
🇫🇷

Centre Georges François Leclerc, Dijon, Bourgogne, France

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy